DBCO-Val-Cit-PAB-MMAE, CAS 2768446-73-5

Product Description: DBCO-Val-Cit-PAB-MMAE is a drug-linker conjugate, which can be used for the synthesis of ADC molecules. MMAE (HY-15162) is a tubulin inhibitor, which can be used as an ADC toxin. DBCO-Val-Cit-PAB is the linker with the electrophilic group[1].

Applications: Cancer-programmed cell death

Formula: C77H107N11O14

References: [1]Huang W, et al., Affinity fragment-directed cleavable fragments, their design, synthesis and use in the preparation of site-directed drug conjugates. CN116836235 A.

CAS Number: 2768446-73-5

Molecular Weight: 1410.74

Research Area: Cancer

Target: Drug-Linker Conjugates for ADC

• Artikelnummer: MEXHY-W591408-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-W591408-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK